AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 38773658 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous glucose monitoring (CGM) device use
Number of subjects: 0
Study 38773658 — intervention group
Group type: EXPERIMENTAL
Intervention: Periodic glucose monitoring (CGM) device use
Number of subjects: 0
Study 38773658 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 0
Study 38773662 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine home-based management program including support from a nursing case manager, daily physical activity stimulation, teleconsultations, telemonitoring, and an app for monitoring clinical parameters.
Number of subjects: 0
Study 38773662 — intervention group
Group type: COMPARATOR
Intervention: Routine care (Control group).
Number of subjects: 0
Study 38773662 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine home-based management program.
Number of subjects: 0
Study 38773832 — intervention group
Group type: EXPERIMENTAL
Intervention: Comorbidity
Number of subjects: 995
Study 38773832 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative time >180 minutes
Number of subjects: 995
Study 38773832 — intervention group
Group type: EXPERIMENTAL
Intervention: Female sex
Number of subjects: 995
Study 38773832 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal anastomosis
Number of subjects: 995
Study 38773832 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall surgical site infection
Number of subjects: 995
Study 38773832 — intervention group
Group type: EXPERIMENTAL
Intervention: Incisional surgical site infection
Number of subjects: 995
Study 38773832 — intervention group
Group type: EXPERIMENTAL
Intervention: Organ/space surgical site infection
Number of subjects: 995
Study 38773832 — intervention group
Group type: EXPERIMENTAL
Intervention: Side-to-side anastomosis
Number of subjects: 995
Study 38773832 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes
Number of subjects: 995
Study 38773832 — intervention group
Group type: EXPERIMENTAL
Intervention: Conversion to open surgery
Number of subjects: 995
Study 38774010 — intervention group
Group type: EXPERIMENTAL
Intervention: Tafamidis (20 mg and 80 mg pooled)
Number of subjects: 0
Study 38774010 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 38774037 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended-release once-nightly sodium oxybate (ON-SXB)
Number of subjects: 0
Study 38774037 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 38774367 — intervention group
Group type: EXPERIMENTAL
Intervention: PPG-guided algorithm for blood pressure measurement
Number of subjects: 97
Study 38774367 — intervention group
Group type: COMPARATOR
Intervention: Cuff-based initialization measurements
Number of subjects: 97
Study 38774367 — intervention group
Group type: EXPERIMENTAL
Intervention: PPG-based BP algorithm
Number of subjects: 97
Study 38774370 — intervention group
Group type: EXPERIMENTAL
Intervention: Voice-assisted technology (Amazon Alexa) for SARS-CoV2 screening questionnaire
Number of subjects: 52
Study 38774370 — intervention group
Group type: COMPARATOR
Intervention: Healthcare personnel for SARS-CoV2 screening questionnaire
Number of subjects: 52
Study 38774377 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital recruitment and screening for atrial fibrillation
Number of subjects: 10582
Study 38774381 — intervention group
Group type: EXPERIMENTAL
Intervention: Consumer wearable device (wrist-worn) monitoring heart rate (HR) using photoplethysmography (PPG)
Number of subjects: 0
Study 38774381 — intervention group
Group type: COMPARATOR
Intervention: Implantable loop recorder (ILR)
Number of subjects: 0
Study 38774417 — intervention group
Group type: EXPERIMENTAL
Intervention: CEUS LR-5
Number of subjects: 119
Study 38774417 — intervention group
Group type: EXPERIMENTAL
Intervention: EOB-MRI LR-5
Number of subjects: 119
Study 38774417 — intervention group
Group type: COMPARATOR
Intervention: CEUS and EOB-MRI
Number of subjects: 119
Study 38774417 — intervention group
Group type: EXPERIMENTAL
Intervention: New criteria (CEUS LR-5 and EOB-MRI LR-4/5 or CEUS LR-4/5 and EOB-MRI LR-5)
Number of subjects: 119
Study 38774425 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct factor Xa inhibitors (apixaban, edoxaban, rivaroxaban)
Number of subjects: 0
Study 38774484 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal remimazolam 1.5mg/kg
Number of subjects: 90
Study 38774484 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 90
Study 38774484 — intervention group
Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 90
Study 38774675 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG-Denmark (single 0.1 ml intradermal injection)
Number of subjects: 6828
Study 38774675 — intervention group
Group type: COMPARATOR
Intervention: Control (no BCG)
Number of subjects: 6828
Study 38774780 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral Activation (BA) therapy for 9 weeks
Number of subjects: 13
Study 38775072 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum progesterone (P) levels measured at 08:00h, 12:00h, 16:00h, and 20:00h on the day of FET.
Number of subjects: 22
Study 38775119 — intervention group
Group type: EXPERIMENTAL
Intervention: MDR + EGE
Number of subjects: 251
Study 38775119 — intervention group
Group type: COMPARATOR
Intervention: EGE only
Number of subjects: 251
Study 38775162 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-based eHealth intervention (up to three sessions)
Number of subjects: 149
Study 38775162 — intervention group
Group type: COMPARATOR
Intervention: Standard medical care control group
Number of subjects: 149
Study 38775253 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous intravenous infusion of loop diuretics
Number of subjects: 681
Study 38775253 — intervention group
Group type: COMPARATOR
Intervention: Bolus injection of loop diuretics
Number of subjects: 681
Study 38775255 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C (1400 mg) plus vitamin E (800 mg)
Number of subjects: 1609
Study 38775255 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc
Number of subjects: 1609
Study 38775255 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 1200 mg
Number of subjects: 1609
Study 38775255 — intervention group
Group type: EXPERIMENTAL
Intervention: L-arginine
Number of subjects: 1609
Study 38775255 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3
Number of subjects: 1609
Study 38775275 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct-to-participant methods for remote enrollment and follow-up
Number of subjects: 5598
Study 38775275 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly surveys and biweekly nasal sampling
Number of subjects: 5598
Study 38775275 — intervention group
Group type: EXPERIMENTAL
Intervention: Longitudinal sampling of host nasal transcriptome
Number of subjects: 5598
Study 38775299 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow dialysis
Number of subjects: 32
Study 38775299 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard sodium dialysate
Number of subjects: 32
Study 38775299 — intervention group
Group type: COMPARATOR
Intervention: Sodium modelling
Number of subjects: 32
Study 38775299 — intervention group
Group type: COMPARATOR
Intervention: High sodium dialysate
Number of subjects: 32
Study 38775302 — intervention group
Group type: EXPERIMENTAL
Intervention: Zanubrutinib (Bruton tyrosine kinase inhibitor); specific dosage and duration not mentioned.
Number of subjects: 0
Study 38775310 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold Snare Polypectomy (CSP)
Number of subjects: 386
Study 38775310 — intervention group
Group type: COMPARATOR
Intervention: Hot Snare Polypectomy (HSP)
Number of subjects: 386
Study 38775310 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold Snare Polypectomy (CSP) with IPPB
Number of subjects: 386
Study 38775331 — intervention group
Group type: EXPERIMENTAL
Intervention: Own oocytes - PGT-A analyzed embryos
Number of subjects: 3741
Study 38775331 — intervention group
Group type: COMPARATOR
Intervention: Own oocytes - Untested embryos
Number of subjects: 3741
Study 38775331 — intervention group
Group type: EXPERIMENTAL
Intervention: Own oocytes - pET-ERA analyzed embryos
Number of subjects: 3741
Study 38775331 — intervention group
Group type: EXPERIMENTAL
Intervention: Own oocytes - PGT-A + pET-ERA analyzed embryos
Number of subjects: 3741
Study 38775331 — intervention group
Group type: EXPERIMENTAL
Intervention: Donated oocytes - PGT-A analyzed embryos
Number of subjects: 3741
Study 38775331 — intervention group
Group type: EXPERIMENTAL
Intervention: Donated oocytes - pET-ERA analyzed embryos
Number of subjects: 3741
Study 38775331 — intervention group
Group type: COMPARATOR
Intervention: Donated oocytes - Untested embryos
Number of subjects: 3741
Study 38775331 — intervention group
Group type: EXPERIMENTAL
Intervention: Donated oocytes - PGT-A + pET-ERA analyzed embryos
Number of subjects: 3741
Study 38775618 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic gastrectomy (RG)
Number of subjects: 527
Study 38775632 — intervention group
Group type: EXPERIMENTAL
Intervention: Individually tailored oral health intervention provided by a dental hygienist focusing on oral hygiene and self-care.
Number of subjects: 174
Study 38775632 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned).
Number of subjects: 174
Study 38775637 — intervention group
Group type: EXPERIMENTAL
Intervention: Belimumab (BEL)
Number of subjects: 1245
Study 38775637 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1245
Study 38775645 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedicled technique
Number of subjects: 165
Study 38775645 — intervention group
Group type: COMPARATOR
Intervention: Surgical skeletonized technique
Number of subjects: 165
Study 38775645 — intervention group
Group type: COMPARATOR
Intervention: Skeletonized with Thunderbeat
Number of subjects: 165
Study 38775645 — intervention group
Group type: EXPERIMENTAL
Intervention: All techniques
Number of subjects: 165
Study 38775718 — intervention group
Group type: EXPERIMENTAL
Intervention: irinotecan-cetuximab
Number of subjects: 102
Study 38775718 — intervention group
Group type: COMPARATOR
Intervention: modified ramucirumab (irinotecan-cetuximab with ramucirumab)
Number of subjects: 102
Study 38775857 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluid balance management during the initial 8 days post-aSAH
Number of subjects: 237
Study 38775857 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluid balance
Number of subjects: 237
Study 38775857 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfusion
Number of subjects: 237
Study 38775857 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluid overload
Number of subjects: 237
Study 38775910 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed-Dose Combination Product (FDCP) of amlodipine, losartan, ezetimibe, and rosuvastatin
Number of subjects: 60
Study 38775910 — intervention group
Group type: COMPARATOR
Intervention: Individual tablets of amlodipine, losartan, ezetimibe, and rosuvastatin
Number of subjects: 60
Study 38775910 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed-Dose Combination Product (FDCP)
Number of subjects: 60
Study 38775910 — intervention group
Group type: COMPARATOR
Intervention: Individual products
Number of subjects: 60
Study 38775922 — intervention group
Group type: EXPERIMENTAL
Intervention: Beam walking on 8-cm wide beam
Number of subjects: 196
Study 38775922 — intervention group
Group type: EXPERIMENTAL
Intervention: Beam walking on 4-cm wide beam
Number of subjects: 196
Study 38775922 — intervention group
Group type: EXPERIMENTAL
Intervention: Beam walking under single and dual-task conditions
Number of subjects: 196
Study 38775925 — intervention group
Group type: EXPERIMENTAL
Intervention: Fezolinetant 30 mg
Number of subjects: 1022
Study 38775925 — intervention group
Group type: EXPERIMENTAL
Intervention: Fezolinetant 45 mg
Number of subjects: 1022
Study 38775925 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1022
Study 38775927 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine colostrum (BC)
Number of subjects: 229
Study 38775927 — intervention group
Group type: COMPARATOR
Intervention: Conventional fortifier
Number of subjects: 229
Study 38776067 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacrocolpopexy
Number of subjects: 376
Study 38776067 — intervention group
Group type: EXPERIMENTAL
Intervention: Transvaginal mesh
Number of subjects: 376
Study 38776067 — intervention group
Group type: COMPARATOR
Intervention: Native tissue repair
Number of subjects: 376
Study 38776067 — intervention group
Group type: EXPERIMENTAL
Intervention: All surgeries
Number of subjects: 376
Study 38776097 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual DCCV (200 J using 2 sets of pads)
Number of subjects: 200
Study 38776097 — intervention group
Group type: COMPARATOR
Intervention: Single DCCV (200 J using 1 set of pads)
Number of subjects: 200
Study 38776097 — intervention group
Group type: COMPARATOR
Intervention: Single DCCV (200 J using 1 set of pads) after failure
Number of subjects: 200
Study 38776097 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual DCCV and Single DCCV
Number of subjects: 200
Study 38776275 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerliponase alfa
Number of subjects: 23
Study 38776307 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based exercise program (aerobic and resistance exercise) over 12 weeks
Number of subjects: 0
Study 38776307 — intervention group
Group type: COMPARATOR
Intervention: Matched individuals without T1D (control group)
Number of subjects: 0
Study 38776334 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiretroviral therapy
Number of subjects: 1373
Study 38776391 — intervention group
Group type: EXPERIMENTAL
Intervention: BNT142 RNA-LNP (0.1- to 1-μg dose range)
Number of subjects: 0
Study 38776391 — intervention group
Group type: EXPERIMENTAL
Intervention: BNT142 RNA-LNP
Number of subjects: 0
Study 38776391 — intervention group
Group type: EXPERIMENTAL
Intervention: RiboMab02.1
Number of subjects: 0
Study 38776446 — intervention group
Group type: EXPERIMENTAL
Intervention: Parosmia
Number of subjects: 250
Study 38776446 — intervention group
Group type: EXPERIMENTAL
Intervention: Phantosmia
Number of subjects: 250
Study 38776484 — intervention group
Group type: EXPERIMENTAL
Intervention: Ruxolitinib 15 mg PO twice a day with paclitaxel/carboplatin chemotherapy
Number of subjects: 147
Study 38776484 — intervention group
Group type: COMPARATOR
Intervention: Standard chemotherapy (paclitaxel/carboplatin)
Number of subjects: 147
Study 38776498 — intervention group
Group type: EXPERIMENTAL
Intervention: COVID-19 public health intervention
Number of subjects: 0
Study 38776515 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment options based on PROSPECT trial data
Number of subjects: 0
Study 38776517 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial intelligence in diagnostic imaging
Number of subjects: 0
Study 38776517 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial intelligence in prediction of outcomes
Number of subjects: 0
Study 38776517 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial intelligence in histopathology
Number of subjects: 0
Study 38776517 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial intelligence in treatment planning
Number of subjects: 0
Study 38776543 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimicrobial Photodynamic Therapy (a specific intervention for root canal disinfection)
Number of subjects: 0
Study 38776543 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in the abstract)
Number of subjects: 0
Study 38776589 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile PASS service
Number of subjects: 418
Study 38776635 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention M (influenza vaccine messaging platform: video, flyer, scripted message, vaccine acceptance question, provider notification)
Number of subjects: 767
Study 38776635 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention Q (no messaging, vaccine acceptance question, provider notification)
Number of subjects: 767
Study 38776635 — intervention group
Group type: COMPARATOR
Intervention: Control (usual care/no intervention)
Number of subjects: 767
Study 38776640 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone
Number of subjects: 3445
Study 38776640 — intervention group
Group type: COMPARATOR
Intervention: Noncardiovascular death
Number of subjects: 3445
Study 38776754 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary sulfur amino acid restriction (SAAR) (∼2 g SAA)
Number of subjects: 59
Study 38776754 — intervention group
Group type: COMPARATOR
Intervention: Control diet (∼5.6 g SAA)
Number of subjects: 59
Study 38776914 — intervention group
Group type: EXPERIMENTAL
Intervention: Iberdomide treatment
Number of subjects: 0
Study 38777128 — intervention group
Group type: EXPERIMENTAL
Intervention: Tirzepatide 5 mg
Number of subjects: 0
Study 38777128 — intervention group
Group type: EXPERIMENTAL
Intervention: Tirzepatide 10 mg
Number of subjects: 0
Study 38777128 — intervention group
Group type: EXPERIMENTAL
Intervention: Tirzepatide 15 mg
Number of subjects: 0
Study 38777128 — intervention group
Group type: COMPARATOR
Intervention: Semaglutide 0.5 mg (Control)
Number of subjects: 0
Study 38777128 — intervention group
Group type: EXPERIMENTAL
Intervention: Tirzepatide (all doses)
Number of subjects: 0
Study 38777276 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) task
Number of subjects: 98
Study 38777276 — intervention group
Group type: EXPERIMENTAL
Intervention: Feeling like punishing oneself
Number of subjects: 98
Study 38777276 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline symptom factor
Number of subjects: 98
Study 38777276 — intervention group
Group type: EXPERIMENTAL
Intervention: Maudsley Staging Method treatment-resistance scores
Number of subjects: 98
Study 38777289 — intervention group
Group type: EXPERIMENTAL
Intervention: High and Consistent Anxiety group
Number of subjects: 117
Study 38777393 — intervention group
Group type: COMPARATOR
Intervention: Community-based NCD screening and management programme in Indonesia
Number of subjects: 0
Study 38777393 — intervention group
Group type: COMPARATOR
Intervention: Community-based NCD screening and management programme in Viet Nam
Number of subjects: 0
Study 38777422 — intervention group
Group type: EXPERIMENTAL
Intervention: BCAA supplementation
Number of subjects: 220
Study 38777422 — intervention group
Group type: EXPERIMENTAL
Intervention: Programmed exercise
Number of subjects: 220
Study 38777422 — intervention group
Group type: EXPERIMENTAL
Intervention: BCAA supplementation and programmed exercise
Number of subjects: 220
Study 38777422 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 220
Study 38777421 — intervention group
Group type: EXPERIMENTAL
Intervention: Refeeding syndrome diagnosed using traditional criterion (TC)
Number of subjects: 85
Study 38777421 — intervention group
Group type: EXPERIMENTAL
Intervention: Refeeding syndrome diagnosed using Friedli consensus recommendations
Number of subjects: 85
Study 38777421 — intervention group
Group type: EXPERIMENTAL
Intervention: Refeeding syndrome diagnosed using ASPEN criteria
Number of subjects: 85
Study 38777421 — intervention group
Group type: COMPARATOR
Intervention: Patients without refeeding syndrome
Number of subjects: 85
Study 38777473 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary transitional nutritional intervention
Number of subjects: 130
Study 38777473 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 130
Study 38777559 — intervention group
Group type: EXPERIMENTAL
Intervention: Recommendation and a text-based intervention aimed at generating intention and motivation to get screened
Number of subjects: 114
Study 38777559 — intervention group
Group type: COMPARATOR
Intervention: Recommendation for CRC screening only
Number of subjects: 114
Study 38777585 — intervention group
Group type: EXPERIMENTAL
Intervention: Coproduction approach, process of coproduction, multi-sector stakeholder group, possibility of active participation, coordinating role of researchers, communication, atmosphere and interaction
Number of subjects: 7
Study 38777585 — intervention group
Group type: EXPERIMENTAL
Intervention: Differences in roles and hierarchy, merging of different perspectives, clarification of intervention costs, competition and conflicting interests
Number of subjects: 7
Study 38777585 — intervention group
Group type: EXPERIMENTAL
Intervention: Coproduction method
Number of subjects: 7
Study 38777585 — intervention group
Group type: EXPERIMENTAL
Intervention: Effective management of power differences among stakeholders
Number of subjects: 7
Study 38777939 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified fasting with dietary and lifestyle modifications
Number of subjects: 114
Study 38778036 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac Magnetic Resonance (CMR)
Number of subjects: 87
Study 38778211 — intervention group
Group type: EXPERIMENTAL
Intervention: CYP-001 (iPS cell-derived mesenchymal stromal cells)
Number of subjects: 15
Study 38778264 — intervention group
Group type: EXPERIMENTAL
Intervention: Morning light treatment for 4 weeks
Number of subjects: 68
Study 38778264 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU) for 4 weeks
Number of subjects: 68
Study 38778289 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized exercise guidance
Number of subjects: 312
Study 38778289 — intervention group
Group type: COMPARATOR
Intervention: Standard prenatal care
Number of subjects: 312
Study 38778292 — intervention group
Group type: EXPERIMENTAL
Intervention: Persian version of the Low Physical Activity Questionnaire (LoPAQ)
Number of subjects: 120
Study 38778345 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemonitoring intervention with self-monitoring of blood glucose (SMBG) combined with sleep and mental health monitoring
Number of subjects: 60
Study 38778345 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemonitoring intervention with SMBG, sleep and mental health monitoring, plus blood pressure and activity monitoring
Number of subjects: 60
Study 38778345 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly defined in the abstract)
Number of subjects: 60
Study 38778383 — intervention group
Group type: EXPERIMENTAL
Intervention: 9-week web-based group training guided by a facilitator
Number of subjects: 150
Study 38778383 — intervention group
Group type: EXPERIMENTAL
Intervention: 9-week web-based self-help training
Number of subjects: 150
Study 38778383 — intervention group
Group type: COMPARATOR
Intervention: treatment as usual
Number of subjects: 150
Study 38778416 — intervention group
Group type: EXPERIMENTAL
Intervention: Early progressive mobilization (EPM)
Number of subjects: 65